235 related articles for article (PubMed ID: 7645966)
21. Antileukemic and cytogenetic activity by triple administration of three modified steroidal derivatives of nitrogen mustards.
Fousteris MA; Papageorgiou A; Arsenou ES; Koutsourea AI; Karaberis E; Mourelatos D; Onyango DO; Nikolaropoulos SS
Chemotherapy; 2007; 53(2):118-26. PubMed ID: 17308378
[TBL] [Abstract][Full Text] [Related]
22. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
23. Induction of cytogenetic damage by modified steroidal derivatives of p-bis(2-chloroethyl)aminophenylacetic acid in human lymphocytes.
Mourelatos D; Petrou C; Boutis L; Papageorgiou A; Catsoulacos P; Dozi-Vassiliades J
Mutat Res; 1987 Mar; 190(3):205-10. PubMed ID: 3821781
[TBL] [Abstract][Full Text] [Related]
24. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
[TBL] [Abstract][Full Text] [Related]
25. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
[TBL] [Abstract][Full Text] [Related]
26. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazides.
Gugova RG; Raikov ZD; Zakhariev SG; Demirov GD; Todorov DK; Ilarionova MV
Drugs Exp Clin Res; 1989; 15(10):497-500. PubMed ID: 2632217
[TBL] [Abstract][Full Text] [Related]
28. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
[TBL] [Abstract][Full Text] [Related]
29. Pyrimidoacridine derivatives as potential antitumor agents.
Antonini I; Cola D; Martelli S; Cholody WM; Konopa J
Farmaco; 1992; 47(7-8):1035-46. PubMed ID: 1445611
[TBL] [Abstract][Full Text] [Related]
30. Enhanced cytogenetic and antineoplastic effects by the combined action of two esteric steroidal derivatives of nitrogen mustards.
Papageorgiou A; Nikolaropoulos SS; Arsenou ES; Karaberis E; Mourelatos D; Kotsis A; Chryssogelou E
Chemotherapy; 1999; 45(1):61-7. PubMed ID: 9876211
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic and antineoplastic effects of modified steroidal alkylators.
Karapidaki I; Papageorgiou A; Geromichalos G; Fousteris M; Papaconstadinou I; Pairas G; Koutsourea A; Mourelatos D; Nikolaropoulos S; Lialiaris T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):93-7. PubMed ID: 20025537
[TBL] [Abstract][Full Text] [Related]
32. Hybrid anticancer compounds. Steroidal lactam esters of carboxylic derivatives of N,N-bis (2-chloroethyl) aniline (review).
Catsoulacos P; Catsoulacos D
Anticancer Res; 1991; 11(5):1773-7. PubMed ID: 1768051
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
[TBL] [Abstract][Full Text] [Related]
34. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
[No Abstract] [Full Text] [Related]
35. In vitro antigenotoxic potential of acitretin in human lymphocytes treated with the antineoplastic alkylating agent ASE (NSC-71964).
Stephanou G; Andrianopoulos C; Tyrakis M; Konti M; Demopoulos NA; Tsambaos D
Toxicol In Vitro; 2004 Oct; 18(5):609-16. PubMed ID: 15251178
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
[TBL] [Abstract][Full Text] [Related]
37. A comparative study on cytogenetic and antineoplastic effects induced by two modified steroidal alkylating agents.
Papageorgiou A; Tsavdaridis D; Geromichalos GD; Camoutsis C; Karaberis E; Mourelatos D; Chrysogelou E; Houvartas S; Kotsis A
Cancer Detect Prev; 2001; 25(4):369-74. PubMed ID: 11531014
[TBL] [Abstract][Full Text] [Related]
38. The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic potency of chlorambucil's active metabolite steroidal esters.
Arsenou ES; Fousteris MA; Koutsourea AI; Papageorgiou A; Karayianni V; Mioglou E; Iakovidou Z; Mourelatos D; Nikolaropoulos SS
Anticancer Drugs; 2004 Nov; 15(10):983-90. PubMed ID: 15514568
[TBL] [Abstract][Full Text] [Related]
39. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
